India approves J&J’S single-dose vaccine

India has granted Johnson & Johnson’s singledose Covid-19 vaccine emergency use authorisation, Union health minister Mansukh Mandaviya said on Saturday, making it the fifth vaccine and the second foreign-made shot to be cleared for use in the country.

The pharmaceutical company, however, said it was too early to give a delivery timeline for the vaccine. It said earlier on Friday that it applied for emergency use approval. The vaccine will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, J&J has said.

“India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation’s collective fight against #COVID19,” the Union health minister tweeted

NEW DELHI:

efficacy in different trials

Single-dose administration

“India expands its vaccine basket”: on Saturday.

Apart from the J&J vaccine, the four other Covid-19 shots approved for emergency use in India are Bharat Biotech’s Covaxin, Serum Institute of India’s Covishield, the Russianmade Sputnik V, and the Moderna vaccine.

“While we look forward to meeting our delivery commitments, it is premature for us to speculate on the timing of our vaccine deliveries,” the company told Reuters.

The J&J vaccine, which has shown 66-72% efficacy in different trials, has been approved by regulators in the US, UK,